Expert Guidance on Treatment Advances in Acute Myeloid Leukemia

Join us for a live local workshop on managing AML with immunotherapeutic agents and novel targeted agents and planning therapy for older patients patients with comorbidities and those who do not have hematopoietic stem cell transplantation. Downloadable slidesets and an on-demand webcast will also be available.

Share

Program Content

Activities

Treatment Advances: AML
Expert Guidance on Treatment Advances in Acute Myeloid Leukemia
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: February 07, 2022

Expires: February 06, 2023

Activities

AML Downloadable Slides
Expert Guidance on Treatment Advances in Acute Myeloid Leukemia
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 21, 2021

Expires: October 20, 2022

Faculty

cover img faculity

Amir Fathi, MD

Assistant Professor of Medicine
Department of Medicine
Harvard Medical School
Division of Hematology/Oncology
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

cover img faculity

Thomas William LeBlanc, MD, MA, MHS, FAAHPM, FASCO

Associate Professor of Medicine
Associate Professor in Population Health Sciences

Duke University School of Medicine
Duke Cancer Institute
Durham, North Carolina

cover img faculity

Eunice S. Wang, MD

Chief, Leukemia/Benign Hematology Service
Professor of Oncology
Roswell Park Comprehensive Cancer Center
Buffalo, New York

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Astellas Text

Bristol Myers Squibb

Genentech, a member of the Roche Group

Jazz Pharmaceuticals Inc